Sarepta Therapeutics: RBC cuts target price to $17 from $19
SRPT•RBC cut its target price for Sarepta Therapeutics to $17 from $19.
Related News
Wall Street winces at bond squeeze
SPY•
United Parks & Resorts target price cut to $34 from $49
PRKS•
PBF Energy: Mizuho raises target price to $89 from $65
PBF•
Charlton Aria agrees to merge with KQC Quantum in deal taking company public on Nasdaq
CHAR•
Phillips 66 cut to neutral from outperform; target price raised to $300 from $220
PSX•